Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997

Medical Journal of Australia

Volumn 172, Issue 2, 2000, Pages 57-61

  MacDonald, Margaret A ^a   Wodak, Alex D ^b   Dolan, Kate A ^c   Van Beek, Ingrid ^d   Cunningham, Philip H ^b   Kaldor, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; SEROPREVALENCE;

EID: 0034676998     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139199.x     Document Type: Article

References (14)

1. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes and cofactors. Epidemiol Rev 1996; 18: 137-148.
2. Crofts N, Jolley D, Kaldor J, et al. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51: 692-697.
3. Seeff LB. Natural history of hepatitis C. Hepatol 1997; 3 Suppl: 21S-28S.
4. Blewett N. National Campaign against drug abuse: Assumptions, arguments, and aspiration. Canberra: AGPS, 1987. (NCADA Monograph No. 1.)
5. Wodak A, Lurie P. A tale of two countries: Attempts to control HIV among injecting drug users in Australia and the United States. J Drug Issues 1996; 27: 117-134.
6. MacDonald M, Wodak A, Ali R, et al, on behalf of the Collaboration of Australian Needle Exchanges. HIV prevalence and risk behaviour in needle exchange attenders: a national study. Med J Aust 1997; 166: 237-240.
7. van Beek I, Dwyer R, Dore GJ, et al. Infection with HIV and hepatitis C among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 317: 433-437.
8. Stata Statistics/Data Analysis [computer program]. Version 5.0. Texas: Stata Corporation, 1997.
9. Bell J, Batey RG, Farrell GC, et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 217-273.
10. Crofts N, Hopper JL, Milner R, et al. Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV. European J Epidemiol 1994; 10: 687-694.
11. Broers B, Junet C, Bourquin M, et al. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 1998; 12: 2509-2066.
12. Goldberg D, Cameron S, McMenamin J. Hepatitis C antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health 1998; 1: 95-97.
13. Crofts N, Webb-Pullman J, Dolan K. An analysis of trends over time in social and behavioural factors related to the transmission of HIV among injecting drug users and prison inmates. Evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Technical Appendix 4. Canberra: AGPS, 1996.
14. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human t-lymphotropic viruses. Am J Public Health 1996; 86: 655-661.